कृपया अन्य खोज का प्रयास करें
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Christopher J. Calise | 50 | 2017 | Independent Director |
Evren Alici | - | 2022 | Member of Scientific & Clinical Advisory Board |
Philippe Deschamps | 62 | 2022 | Independent Director |
Tara Maria DeSilva | 55 | 2022 | Independent Director |
David Mehalick | 55 | 2016 | Co-Founder, Chairman of the Board, CEO & President |
Arnika Kathleen Wagner | - | 2022 | Member of Scientific & Clinical Advisory Board |
Hans-Gustaf Ljunggren | - | 2022 | Member of Scientific & Clinical Advisory Board |
Eugene Z. Salkind | 70 | 2022 | Independent Director |
Daniel Alexander Yerace | 41 | 2021 | Co-Founder, VP of Operations & Director |
Christopher Patrick Cochran | 54 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है